C. Durieux

发表

Antidepressant‐like effects of CCKB antagonists in mice: antagonism by naltrindole

B. Roques, M. Derrien, C. Durieux, 1994, British journal of pharmacology.

Electrophysiological studies with new CCK analogs: Correlation with binding affinity on B-type receptors

B. Roques, G. Böhme, J. Stutzmann, 1989, Peptides.

1H NMR conformational study of sulfated and non-sulfated cholecystokinin fragment CCK27-33: influence of the sulfate group on the peptide folding.

B. Roques, J. Lallemand, M. Fournié-Zaluski, 1983, Biochemical and biophysical research communications.

C-fos antisense oligodeoxynucleotide increases formalin-induced nociception and regulates preprodynorphin expression

J. C. Hunter, J. Hughes, C. Durieux, 1995, Neuroscience.

The in vivo metabolism of cholecystokinin (CCK-8) is essentially ensured by aminopeptidase A

B. Roques, M. Migaud, M. Fournié-Zaluski, 1996, Peptides.

Slow Delivery of the Selective Cholecystokinin Agonist pBC 264 into the Rat Nucleus Accumbens Using Microspheres

P. Couvreur, B. Roques, E. Fattal, 1996, Journal of neurochemistry.

Pharmacological properties of ureido-acetamides, new potent and selective non-peptide CCKB/gastrin receptor antagonists.

B. Ducos, G. Böhme, M. Capet, 1994, European journal of pharmacology.

Cholecystokinin peptidomimetics as selective CCK-B antagonists: design, synthesis, and in vitro and in vivo biochemical properties.

B. Roques, B. Ducos, C. Durieux, 1993, Journal of medicinal chemistry.

In vivo binding affinities of cholecystokinin agonists and antagonists determined using the selective CCKB agonist [3H]pBC 264.

B. Roques, M. Ruiz‐Gayo, C. Durieux, 1991, European journal of pharmacology.

Human apolipoprotein B. Evidence for its immunochemical heterogeneity using monoclonal antibodies and an immunoenzymometric assay.

J. Fruchart, C. Fiévet, J. Lecocq, 1988, Clinical biochemistry.

Solid phase synthesis of a fully active analogue of cholecystokinin using the acid-stable Boc-Phe (p-CH2) SO3H as a substitute for Boc-Tyr(SO3H) in CCK8.

B. Roques, D. Ficheux, R. González-Muñiz, 2009, International journal of peptide and protein research.

Evidence for a High‐affinity Uptake System for Cholecystokinin Octapeptide (CCK8) in Rat Cortical Synaptosomes

B. Roques, M. Migaud, C. Durieux, 1995, The European journal of neuroscience.

[3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702.

P. Corringer, B. Roques, B. Ducos, 1992, Molecular pharmacology.

Multiple cleavage sites of cholecystokinin heptapeptide by “enkephalinase”

B. Roques, D. Pélaprat, G. Gacel, 1985, Peptides.

Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism.

J. Crawley, B. Roques, M. Derrien, 1991, The Journal of pharmacology and experimental therapeutics.

[Co-localization of CCK and dopamine. Biochemical and pharmacological aspects].

B. Roques, D. Pélaprat, V. Daugé, 1989, L'Encephale.

Characterization of [3H] CCK4 binding sites in mouse and rat brain

B. Roques, D. Pélaprat, B. Charpentier, 1988, Neuropeptides.

Cholecystokinin-A receptor mediation of food intake in cats.

B. Roques, A. Bado, C. Durieux, 1991, The American journal of physiology.

Conformational behavior of cyclic CCK‐related peptides determined by 400‐MHz 1H‐nmr: Relationships with affinity and selectivity for brain receptors

B. Roques, B. Charpentier, C. Durieux, 1989, Biopolymers.

Investigation of behavioral and electrophysiological responses induced by selective stimulation of CCKB receptors by using a new highly potent CCK analog, BC 264

J. Féger, J. Crawley, B. Roques, 1990, Synapse.

Involvement of D2 dopaminergic receptors in the emotional and motivational responses induced by injection of CCK-8 in the posterior part of the rat nucleus accumbens

B. Roques, M. Derrien, C. Durieux, 1993, Brain Research.

Occurrence of two cholecystokinin binding sites in guinea-pig brain cortex.

B. Roques, M. Coppey, J. Zajac, 1986, Biochemical and biophysical research communications.

Studies on the Conformation, Enzymatic Degradation, Pharmacological Potency, and Binding Properties in Brain Tissue of Cholecystokinin‐8 and New Related Peptides a

B. Roques, D. Pélaprat, M. Ruiz‐Gayo, 1985, Annals of the New York Academy of Sciences.

CholecystokininA and cholecystokininB receptors in neurons of the brainstem solitary complex of the rat: pharmacological identification.

P. Branchereau, J. Champagnat, M. Denavit-Saubié, 1992, The Journal of pharmacology and experimental therapeutics.

Conformational analysis of cholecystokinin fragments CCK4, CCK5, and CCK6 by 1H‐nmr spectroscopy and fluorescence‐transfer measurements

M. Fournié-Zaluski, B. Roques, J. Belleney, 1985, Biopolymers.

Tritium labelling of two highly selective agonists for CCK‐B receptor: [3H]propionyl‐Tyr(SO3Na)‐gNle‐mGly‐Trp‐(N‐Me)Nle‐Asp‐Phe‐NH2([3H]pBC 264) [3H]propionyl‐γDLys‐Trp‐Nle‐Asp‐Phe‐NH2([3H]pBC 254)

P. Corringer, B. Roques, M. Ruiz‐Gayo, 1992 .

Enzyme-resistant CCK analogs with high affinities for central receptors

B. Roques, D. Pélaprat, B. Charpentier, 1988, Peptides.

Stimulation of δ‐Opioid Receptors Reduces the In Vivo Binding of the Cholecystokinin (CCK)‐B‐Selective Agonist [3H]pBC 264: Evidence for a Physiological Regulation of CCKergic Systems by Endogenous Enkephalins

M. Fournié-Zaluski, B. Roques, M. Ruiz‐Gayo, 1992, Journal of neurochemistry.

Effects of cholecystokinin octapeptide and BC 264, a potent and selective CCK-B agonist on aspartate and glutamate release from rat hippocampal slices

B. Roques, M. Migaud, C. Durieux, 1994, Neuropharmacology.

Heterogeneity of CCK-B receptors involved in animal models of anxiety

B. Roques, B. Ducos, M. Derrien, 1994, Pharmacology Biochemistry and Behavior.

Synthesis and biological properties of Boc-CCK(30–33) derived pseudopeptides with improved bioavailability

P. Corringer, B. Roques, B. Ducos, 1993 .

Replacement of Tyr-SO3H by a p-carboxymethyl-phenylalanine in a CCK8-derivative preserves its high affinity for CCK-B receptor.

B. Roques, D. Ficheux, C. Durieux, 2009, International journal of peptide and protein research.

In vivo binding of [3H]pBC 264, a selective agonist of central CCK receptors

B. Roques, M. Ruiz‐Gayo, C. Durieux, 1991 .

[3H]pBC 264, first highly potent and very selective radioligand for CCK-B receptors.

P. Corringer, B. Roques, F. Bergeron, 1989, European journal of pharmacology.

Investigation of peripheral cholecystokinin receptor heterogeneity by cyclic and related linear analogues of CCK26-33: synthesis and biological properties.

B. Roques, B. Charpentier, C. Durieux, 1987, Journal of Medicinal Chemistry.

Investigation on the metabolism of CCK8 analogues by rat brain slices

B. Roques, D. Pélaprat, B. Charpentier, 1986, Neuropeptides.

[3H] Boc [Nle28, 31]CCK27-33, a new highly labelled ligand for CCK receptors: binding on brain and on pancreas.

B. Roques, D. Pélaprat, G. Gacel, 1985, Life sciences.

Discrimination between CCK receptors of guinea-pig and rat brain by cyclic CCK8 analogues.

B. Roques, B. Charpentier, C. Durieux, 1988, Biochemical and biophysical research communications.

CCK‐B Antagonists Exhibit Antidepressant‐Like Effects and Potentiate Endogenous Enkephalin Analgesia

M. Fournié-Zaluski, O. Valverde, R. Maldonado, 1994, Annals of the New York Academy of Sciences.

Synthesis and binding affinities of cyclic and related linear analogues of CCK8 selective for central receptors.

B. Roques, B. Charpentier, C. Durieux, 1989, Journal of medicinal chemistry.

Cyclic cholecystokinin analogues with high selectivity for central receptors.

B. Roques, D. Pélaprat, B. Charpentier, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Conformational analysis of cholecystokinin CCK26-33 and related fragments by 1H NMR spectroscopy, fluorescence-transfer measurements, and calculations.

B. Roques, B. Maigret, G. Gacel, 1986, Biochemistry.

Boc-Trp-Orn(Z)-Asp-NH2 and derivatives: a new family of CCK antagonists.

B. Roques, R. González-Muñiz, F. Bergeron, 1990, Journal of medicinal chemistry.

Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor.

B. Roques, A. Bado, B. Ducos, 1997, Journal of medicinal chemistry.

CCK-B agonist or antagonist activities of structurally hindered and peptidase-resistant Boc-CCK4 derivatives.

P. Corringer, B. Roques, B. Ducos, 1993, Journal of medicinal chemistry.

Full agonists of CCK8 containing a nonhydrolyzable sulfated tyrosine residue.

B. Roques, D. Pélaprat, J. Blanchard, 1989, Journal of medicinal chemistry.

Dual Modulation of Dopamine Release from Anterior Nucleus Accumbens Through Cholecystokinin‐B Receptor Subsites

B. Roques, C. Durieux, I. Léna, 1997, Journal of neurochemistry.

Degradation Processes and Binding Properties of Cholecystokinin and Related Compounds

D. Pélaprat, M. Fournié-Zaluski, J. Zajac, 1985 .

Cyclic CCK-8 analogs highly selective for central receptors

B. Roques, D. Pélaprat, B. Charpentier, 1988 .

Electroimmuno- and immunonephelometric assays of apolipoprotein A-I by using a mixture of monoclonal antibodies.

J. Fruchart, C. Fiévet, C. Durieux, 1988, Clinical chemistry.

Rat monoclonal antibodies to human apolipoprotein B: advantages and applications.

Y. Marcel, H. Bazin, J. Fruchart, 1989, Journal of lipid research.

Different modifications of the dopamine metabolism in the core and shell parts of the nucleus accumbens following CCK-A receptor stimulation in the shell region

B. Roques, C. Durieux, N. Ladurelle, 1994, Neuroscience Letters.

[Study of induced effects by selective CCKB agonists cholecystokinin in the nociception and behavior in rodents].

P. Corringer, B. Roques, F. Noble, 1992, Therapie.

The effect of c-fos antisense in the formalin-paw test

J. Hunter, J. Hughes, C. Durieux, 1994, Regulatory Peptides.